Lymphovascular space invasion and the treatment of stage I endometrioid endometrial cancer

International Journal of Gynecological Cancer

Volumn 25, Issue 1, 2015, Pages 75-80

  Van Der Putten, Louis J M ^a   Geels, Yvette P ^a   Ezendam, Nicole P M ^b,c   Van Der Putten, Hans W H M ^b,d   Snijders, Marc P M L ^e   Van De Poll Franse, Lonneke V ^b,c   Pijnenborg, Johanna M A ^b,f  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b The Netherlands   (Netherlands)

^c TILBURG UNIVERSITY   (Netherlands)

^d CATHARINA HOSPITAL   (Netherlands)

^e CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^f Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

Author keywords

Adjuvant treatment; Early stage; Endometrial cancer; Endometrioid carcinoma; Lymphovascular space invasion

Indexed keywords

AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENDOMETRIOID ENDOMETRIAL CANCER; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; HYSTERECTOMY; LYMPH NODE DISSECTION; LYMPH VESSEL METASTASIS; LYMPHOVASCULAR SPACE INVASION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SALPINGOOOPHORECTOMY; SYSTEMIC THERAPY; CANCER GRADING; CANCER STAGING; ENDOMETRIAL NEOPLASMS; LYMPH NODE; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; MYOMETRIUM; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; TUMOR INVASION;

ANTINEOPLASTIC AGENT;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; ENDOMETRIAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; MYOMETRIUM; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 84927736999     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0000000000000306     Document Type: Article

References (24)

1. Amant F, Moerman P, Neven P, et al. Endometrial cancer. Lancet. 2005;366:491-505.
2. Uharcek P. Prognostic factors in endometrial carcinoma. J Obstet Gynaecol Res. 2008;34:776-783.
3. Guntupalli SR, Zighelboim I, Kizer NT, et al. Lymphovascular space invasion is an independent risk factor for nodal disease and poor outcomes in endometrioid endometrial cancer. Gynecol Oncol. 2012;124:31-35.
4. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet. 2009; 105:103-104.
5. Creutzberg CL, van Putten WL, Koper PC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: Multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet. 2000;355:1404-1411.
6. Nout RA, Smit VT, Putter H, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): An open-label, non-inferiority, randomised trial. Lancet. 2010;375:816-823.
7. Roper B, Astner ST, Heydemann-Obradovic A, et al. Ten-year data on 138 patients with endometrial carcinoma and postoperative vaginal brachytherapy alone: no need for external-beam radiotherapy in low and intermediate risk patients. Gynecol Oncol. 2007;107:541-548.
8. Endometrial Cancer. Oncoline cancer clinical practice guidelines Web site. Available at: Www.oncoline.nl/endometriumcarcinoom. Accessed January 2013.
9. Gemer O, Arie AB, Levy T, et al. Lymphvascular space involvement compromises the survival of patients with stage I endometrial cancer: results of a multicenter study. Eur J Surg Oncol. 2007;33:644-647.
10. Briet JM, Hollema H, Reesink N, et al. Lymphovascular space involvement: An independent prognostic factor in endometrial cancer. Gynecol Oncol. 2005;96:799-804.
11. O'Brien DJ, Flannelly G, Mooney EE, et al. Lymphovascular space involvement in early stage well-differentiated endometrial cancer is associated with increased mortality. BJOG. 2009;116:991-994.
12. Keys HM, Roberts JA, Brunetto VL, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: A Gynecologic Oncology Group study. Gynecol Oncol. 2004;92:744-751.
13. Cohn DE, Horowitz NS, Mutch DG, et al. Should the presence of lymphovascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer? Gynecol Oncol. 2002;87:243-246.
14. Kumar VJ, Nin CY, Kuei LY, et al. Survival and disease relapse in surgical stage I endometrioid adenocarcinoma of the uterus after adjuvant vaginal vault brachytherapy. Int J Gynecol Cancer. 2010;20:564-569.
15. Aoki Y, Watanabe M, Amikura T, et al. Adjuvant che motherapy as treatment of high-risk stage I and II endometrial cancer. Gynecol Oncol. 2004;94:333-339.
16. Kim YB, Niloff JM. Endometrial carcinoma: Analysis of recurrence in patients treated with a strategy minimizing lymph node sampling and radiation therapy. Obstet Gynecol. 1993;82:175-180.
17. Frimer M, Khoury-Collado F, Murray MP, et al. Micrometastasis of endometrial cancer to sentinel lymph nodes: Is it an artifact of uterine manipulation? Gynecol Oncol. 2010;119:496-499.
18. Kong A, Johnson N, Kitchener HC, et al. Adjuvant radiotherapy for stage I endometrial cancer. Cochrane Database Syst Rev. 2012;3:CD003916.
19. Ronnett BM, Zaino RJ, Hedrick Ellenson L, et al. Endometrial carcinoma. In: Kurman RJ, ed. Blaustein's Pathology of the Female Genital Tract, 5th ed, Baltimore: Springer, 2000:501-546.
20. McCluggage WG, Colgan T, Duggan M, et al. Data set for reporting of endometrial carcinomas: recommendations from the International Collaboration on Cancer Reporting (ICCR) between United Kingdom, United States, Canada, and Australasia. Int J Gynecol Pathol. 2013;32:45-65.
21. Pecorelli S, Benedet JL, Creasman WT, et al. FIGO staging of gynecologic cancer. 1994-1997 FIGO Committee on Gynecologic Oncology. International Federation of Gynecology and Obstetrics. Int J Gynaecol Obstet. 1999;65:243-249.
22. Narayan K, Khaw P, Bernshaw D, et al. Prognostic significance of lymphovascular space invasion and nodal involvement in intermediate- And high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy. Int J Gynecol Cancer. 2012;22:260-266.
23. Narayan K, Rejeki V, Herschtal A, et al. Prognostic significance of several histological features in intermediate and high-risk endometrial cancer patients treated with curative intent using surgery and adjuvant radiotherapy. J Med Imaging Radiat Oncol. 2009;53:107-113.
24. Simpkins F, Papadia A, Kunos C, et al. Patterns of recurrence in stage I endometrioid endometrial adenocarcinoma with lymphovascular space invasion. Int J Gynecol Cancer. 2013;23:98-104.